• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Elucidation of roles of Na^+-driven cation transporter in blood pressure control and arterial lesions

Research Project

Project/Area Number 14570097
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field General pharmacology
Research InstitutionFukuoka University (2003)
National Cardiovascular Center Research Institute (2002)

Principal Investigator

IWAMOTO Takahiro  Fukuoka University, School of Medicine, Lecturer, 医学部, 講師 (20300973)

Project Period (FY) 2002 – 2003
KeywordsNa^+ / Ca^<2+> exchanger / Hypertension / Calcium ion / Salt-sensitivity / Vasodilation
Research Abstract

Excessive salt intake is a major risk factor for hypertension Here we identify the role of Na^+/Ca^<2+> exchanger type 1 (NCX1) in salt-sensitive hypertension using SEA0400, a specific inhibitor for Ca^<2+> entry via NCX1, and genetically engineered mice. SEA0400 lowers arterial blood pressure in salt-dependent hypertensive rat models, but not in normotensive rats or other types of hypertensive rats. Infusion of SEA0400 into the femoral artery in salt-dependent hypertensive rats increases arterial blood flow indicating peripheral vasodilation. SEA0400 reverses ouabain-induced cytosolic Ca^<2+> elevation and vasoconstriction in arteries. Furthermore, heterozygous NCX1-deflcient mice have low salt-sensitivity, whereas transgenic mice that specifically express NCX1.3 in smooth muscle are hypersensitive to salt SEA0400 significantly lowers the blood pressure in salt-dependent hypertensive mice expressing NCX1.3, but not in SEA0400-insensitive NCX1.3 mutants. These findings indicate that salt-sensitive hypertension is triggered by Ca^<2+> entry via NCX1 in arterial smooth muscle and suggest that NCX1 inhibitors might be useful therapeutically.

  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] Matsumura, Y.: "Pathophysiological roles of Ca^<2+> overload via the Na^+/Ca^<2+> exchanger and eddotheline-1 overproduction in ischemia/reperfusion-induced acute renal failure"Clin.Sci.. 103・Suppl48. 389S-392S (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shigekawa, M.: "Probing ion binding sites in Na^+/Ca^<2+> exchanger"Ann.N.Y.Aced.Sci.. 976. 19-30 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岩本隆宏: "遺伝子改変マウスを用いたNa^+/Ca^<2+>交換輸送体の機能解析と創薬"日薬理誌. 120・Suppl1. 91P-93P (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamashita, J.: "Attenuation of ischemia/reperfusion-induced renal injury in mice deficient in Na^+/Ca^<2+> exchanger"J.Pharmacol.Exp.Ther.. 304・1. 284-293 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Wakimoto, K.: "Na^+/Ca^<2+> exchanger-deficient mice have disorganized myofibrls and swollen mitochondria in cardiomyocytes."Comp.Biochem.Physiol.B.Biochem.Mol.Biol.. 135・1. 9-15 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ogata, M.: "A novel and selective Na^+/Ca^<2+> exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury."Eur.J.Pharmacol.. 478・2-3. 187-198 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岩本隆宏: "Na^+/Ca^<2+>交換体と虚血再灌流障害"Heart View. 7・12. 126-131 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Iwamoto, T.: "Molecular determinants of Na^+/Ca^<2+> exchanger (NCX1) inhibition by SEA0400."J.Biol.Chem.. 279・9. 187-198 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岩本隆宏: "Na^+/Ca^<2+>交換体を標的とした虚血治療の新展開"医学のあゆみ. 208・5. 382-387 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Iwamoto, T.: "Development and application of Na^+/Ca^<2+> exchange inhibitors"Mol.Cell.Biochem.. 259・1-2. 157-161 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Iwamoto, T.: "The exchanger inhibitory peptide region-dependent inhibition of Na^+/Ca^<2+> exchange by SN-6[2-[4-(4-nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic acid ethyl esterl, a novel benzyloxyphenyl derivative."Mol.Pharmacol.. in press.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Iwamoto, T.: "Endothelin-1 aggravates hypoxia/reoxygenation-induced injury in renal epithelial cells through the activation of Na^+/Ca^<2+> exchanger."J.Cardiovasc.Pharmacol.. in press.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kita, S.: "Endothelin-1 enhances the activity of Na^+/Ca^<2+> exchanger type 1 (NCX1) in renal epithelial cells."J.Cardiovasc.Pharmacol.. in press.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Matsumura, Y: "Pathophysiological roles of Ca^<2+> overload via the Na^+/Ca^<2+> exchanger and endotheline-1 overproduction in ischemia/reperfusion-induced acute renal failure."Clin.Sci.. 103-Suppl48. 389S-392S (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shigekawa, M: "Probing ion binding sites in Na^+/Ca^<2+> exchanger."Ann.N.Y.Acad.Sci.. 976. 19-30 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwamoto, T.: "Functional analysis of Na^+/Ca^<2+> exchanger using novel drugs and genetically engineered mice."Folia Pharmacol.Jpn.. 120-Suppl1. 91-93 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamashita, J.: "Attenuation of ischemia/reperfusion induced renal injury in mice deficient in Na^+/Ca^<2+> exchanger."J.Pharmacol.Exp.Ther.. 304-1. 284-293 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Wakimoto, K.: "Na^+/Ca^<2+> exchanger-deficient mice have disorganized myofibrils and swollen mitochondria in cardiomyocytes."Comp.Biochem.Physiol.B.Biochem.Mol.Biol.. 135-1. 9-15 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ogata, M.: "A novel and selective Na^+/Ca^<2+> exchanger inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury."Eur.J.Pharmacol. 478-(2-3). 187-198 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwamoto, T.: "Na^+/Ca^<2+> exchanger and ischemia/reperfusion injury."Heart View. 7-12. 126-131 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwamoto, T.: "Molecular determinants of Na^+/Ca^<2+> exchanger (NCX1) inhibition by SEA0400."J.Biol.Chem.. 279-9. 187-198 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwamoto, T.: "New perspective on Na^+/Ca^<2+> exchanger-targeted therapeutics for ischemia."J.Clin.Exper.Med.. 208-5. 382-387 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwamoto, T.: "Development and application of Na^+/Ca^<2+> exchanger inhibitors"Mol.Cell.Biochem.. 259-(1-2). 157-161 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwamoto, T.: "The exchanger inhibitory peptide region-dependent inhibition of Na^+/Ca^<2+> exchanger by SN-6 [2-[4-(4-nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic acid ethyl ester], a novel benzyloxyphenyl derivative."Mol.Pharmacol.. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwamoto, T.: "Endothelin-1 aggravates hypoxia/reoxygenation-induced injury in renal epithelial cells through the activation of Na^+/Ca^<2+> exchanger."J.Cardiovasc.Pharmacol.. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kita, S.: "Endothelin-1 enhances the activity of Na^+/Ca^<2+> exchanger type 1 (NCX1) in renal epithelial cells."J.Cardiovasc.Pharmacol.. (in press).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi